Related Experiment Video
Updated: Jul 17, 2026
09:24
Expanding the Toolkit for In Vivo Imaging of Axonal Transport
Published on: December 23, 2021
Defective axonal transport in motor neuron disease
Ali Morsi El-Kadi1, Violetta Soura, Majid Hafezparast
1Department of Biochemistry, School of Life Sciences, University of Sussex, Brighton, United Kingdom.
Journal of Neuroscience Research
|February 1, 2007
Summary
Axonal transport is crucial in motor neuron diseases. Paradoxically, partially limiting dynein motor function may improve axonal transport, delaying disease progression and extending lifespan in mouse models.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Axonal transport is increasingly recognized as a key factor in motor neuron disease pathogenesis.
- Mutations affecting microtubule dynamics, molecular motors (dynein, kinesins), and vesicle-associated proteins are linked to motor neuron degeneration.
- Previous research implicates disruptions in axonal transport in the development of motor neuron diseases.
Purpose of the Study:
- To investigate the complex role of axonal transport in motor neuron diseases.
- To explore the paradoxical effects of dynein motor function on disease progression.
- To understand how modulating axonal transport might influence disease onset and longevity.
Main Methods:
- Utilized mouse models, including the 'legs at odd angles' (Loa) mouse and a transgenic model for human motor neuron disease.
- Examined the impact of genetic mutations on microtubule regulation and molecular motor function.
- Assessed axonal transport efficiency and its correlation with disease phenotypes.
Main Results:
- Mutations in genes controlling microtubule dynamics and molecular motors cause motor neuron degeneration.
- Evidence suggests that partial limitation of dynein motor function can paradoxically enhance axonal transport.
- In a transgenic mouse model, impaired dynein function led to delayed disease onset and increased lifespan.
Conclusions:
- Axonal transport is a critical determinant in the pathogenesis of motor neuron diseases.
- Modulating the function of molecular motors like dynein presents a potential therapeutic avenue.
- Targeting axonal transport mechanisms may offer strategies for delaying disease progression and improving outcomes in motor neuron diseases.
Related Concept Videos
01:21Neurons: The Axon
Axons are long, cytoplasmic processes of nerve cells capable of propagating electrical impulses known as action potentials. The cytoplasm or axoplasm of an axon contains neurofibrils, neurotubules, small vesicles, lysosomes, mitochondria, and various enzymes, all encased within the axolemma, the plasma membrane of the axon.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
The axon attaches to the cell body at a cone-shaped elevation called the axon hillock. The initial part of the axon, closest to the hillock, is known as the initial segment.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:32Microtubule Associated Motor Proteins
Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular cargos...